We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VM market cap is 13.93M. The company's latest EPS is CAD -0.0105 and P/E is -9.52.
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 4k | 0 |
Operating Income | -415k | -907k | -1.73M | -1.35M | -1.05M |
Net Income | -552k | -1.14M | -2.05M | -1.75M | -1.4M |
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.61M | 1.28M | 2.57M | 2.1M | 2.16M |
Total Liabilities | 852k | 969k | 660k | 631k | 728k |
Total Equity | 754k | 306k | 1.91M | 1.46M | 1.44M |
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -637k | -272k | -1.65M | -1.72M | -991k |
Investing | -170k | -152k | -432k | -274k | -175k |
Financing | 736k | 351k | 2.9M | 1.21M | 1.14M |
Market Cap | 13.93M |
Price to Earnings Ratio | -9.52 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 9.24 |
Dividend Yield | - |
Shares Outstanding | 132.7M |
Average Volume (1 week) | 781.95k |
Average Volume (1 Month) | 256.3k |
52 Week Change | 110.00% |
52 Week High | 0.105 |
52 Week Low | 0.04 |
Spread (Intraday) | 0 (0%) |
Company Name | Voyageur Pharmaceuticals Ltd |
Address |
suite 800, 333 7th avenue sw calgary, alberta T2P 2Z1 |
Website | https://www.voyageurpharmaceuticals.ca |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions